These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30099916)

  • 1. The role of racial/ethnic factors in global clinical trials.
    Ferdinand KC; Igari M
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):829-832. PubMed ID: 30099916
    [No Abstract]   [Full Text] [Related]  

  • 2. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999.
    Evelyn B; Toigo T; Banks D; Pohl D; Gray K; Robins B; Ernat J
    J Natl Med Assoc; 2001 Dec; 93(12 Suppl):18S-24S. PubMed ID: 11798060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the accrual of racial and ethnic minority patients in clinical trials: Time to raise the stakes.
    Ibraheem A; Polite B
    Cancer; 2017 Dec; 123(24):4752-4756. PubMed ID: 29072791
    [No Abstract]   [Full Text] [Related]  

  • 4. Reporting race/ethnicity in epilepsy clinical trials.
    Burneo JG; Martin R
    Epilepsy Behav; 2004 Oct; 5(5):743-5. PubMed ID: 15380128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race, ethnic group, and clinical research.
    Rathore SS; Krumholz HM
    BMJ; 2003 Oct; 327(7418):763-4. PubMed ID: 14525851
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials and transethnic pharmacology.
    Kitler ME
    Drug Saf; 1994 Nov; 11(5):378-91. PubMed ID: 7873093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's race got to do with it?
    Adler J
    Newsweek; 2009 Jan; 153(2):16. PubMed ID: 19209481
    [No Abstract]   [Full Text] [Related]  

  • 8. Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
    Nooka AK; Behera M; Lonial S; Dixon MD; Ramalingam SS; Pentz RD
    Cancer; 2016 Oct; 122(20):3207-3214. PubMed ID: 27404488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race, ethnicity, ancestry, and pharmacogenetics.
    Urban TJ
    Mt Sinai J Med; 2010; 77(2):133-9. PubMed ID: 20309922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvising Race: Clinical Trials and Racial Classification.
    Valdez N
    Med Anthropol; 2019; 38(8):635-650. PubMed ID: 31415217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors.
    Ichimaru K; Toyoshima S; Uyama Y
    Clin Pharmacol Ther; 2010 Mar; 87(3):362-6. PubMed ID: 20107436
    [No Abstract]   [Full Text] [Related]  

  • 12. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial/ethnic differences in drug disposition and response: review of recently approved drugs.
    Ramamoorthy A; Pacanowski MA; Bull J; Zhang L
    Clin Pharmacol Ther; 2015 Mar; 97(3):263-73. PubMed ID: 25669658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond racial and ethnic analyses in clinical research: a proposed model for Institutional Review Boards.
    Eckstein L
    Food Drug Law J; 2011; 66(2):243-63, ii-iii. PubMed ID: 24505842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics. FDA races in wrong direction.
    Haga SB; Venter JC
    Science; 2003 Jul; 301(5632):466. PubMed ID: 12881555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA issues guidance on race and ethnicity data.
    Meadows M
    FDA Consum; 2003; 37(3):36. PubMed ID: 12793392
    [No Abstract]   [Full Text] [Related]  

  • 17. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
    Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
    Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial geography, pharmacogenetics, and global drug development.
    Schuck RN; Florian J; Charlab R; Pacanowski M
    Clin Pharmacol Ther; 2015 Mar; 97(3):218-20. PubMed ID: 25669642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review identified suboptimal reporting and use of race/ethnicity in general medical journals.
    Ma IW; Khan NA; Kang A; Zalunardo N; Palepu A
    J Clin Epidemiol; 2007 Jun; 60(6):572-8. PubMed ID: 17493512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting of race and ethnicity at an international haematology conference.
    Mehta A; Fillmore N; Dahiya S; D'Souza A; Sweetenham J; Kansagra A
    Br J Haematol; 2020 Dec; 191(5):e107-e109. PubMed ID: 32862435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.